توقعات سوق اللقاحات النباتية في أوروبا حتى عام 2028 - تأثير كوفيد-19 والتحليل الإقليمي حسب نوع اللقاح (اللقاحات البكتيرية، واللقاحات الفيروسية، واللقاحات الطفيلية، وغيرها)، والمصدر (نبات التبغ، والذرة، والبطاطس، وغيرها)، والتطبيق ( (الأنفلونزا، فيروس زيكا، فيروس الإيبولا، أمراض الدواجن، وغيرها)

TABLE OF CONTENTS

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Europe Plant-based Vaccines Market – By Vaccine Type

1.3.2        Europe Plant-based Vaccines Market – By Source

1.3.3        Europe Plant-based Vaccines Market – By Application

1.3.4        Europe Plant-based Vaccines Market – By Country

2.           Europe Plant-based Vaccines Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Europe Plant-based Vaccines Market– Market Landscape

4.1         Overview

4.2         Europe PEST Analysis

4.3         Experts Opinion

5.           Europe Plant-based Vaccines Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Significant Rise in Number of Research & Development (R&D) Activities in Plant-Based Vaccines

5.1.2        Infectious Diseases Getting Quite Prevalent

5.2         Market Restraints

5.2.1        Manufacturing Plant-Based Vaccines Facing Potential Risk of Contamination Including Environmental Risks

5.3         Market Opportunities

5.3.1        Production Surge in Plant-Based Vaccines

5.4         Future Trends

5.4.1        High Rise in Product Approvals

5.5         Impact Analysis

6.           Plant-based Vaccines Market– Europe Analysis

6.1         Europe Plant-based Vaccines Market Revenue Forecast and Analysis

7.           Europe Plant-Based Vaccines Market Analysis – By Vaccine Type

7.1         Overview

7.2         Europe Plant-based Vaccines Market Revenue Share, by Vaccine Type (2021 and 2028)

7.3         Bacterial Vaccines

7.3.1        Overview

7.3.2        Bacterial Vaccines: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)

7.4         Viral Vaccines

7.4.1        Overview

7.4.2        Viral Vaccines: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)

7.5         Parasite Vaccines

7.5.1        Overview

7.5.2        Parasite Vaccines: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)

7.6         Plant-derived Virus-like Particles (VLPs)

7.6.1        Overview

7.6.2        Plant-derived Virus-like particles (VLPs): Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)

7.7         Others

7.7.1        Overview

7.7.2        Others: Plant-based Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

8.           Europe Plant-based Vaccines Market Analysis – By Source

8.1         Overview

8.2         Europe Plant-based Vaccines Market Revenue Share, by Source (2021 and 2028)

8.3         Tobacco Plant

8.3.1        Overview

8.3.2        Tobacco Plant: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)

8.4         Maize

8.4.1        Overview

8.4.2        Maize: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)

8.5         Potato

8.5.1        Overview

8.5.2        Potato: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)

8.6         Others

8.6.1        Overview

8.6.2        Others: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)

9.           Europe Plant-based Vaccines Market Analysis– by Application

9.1         Overview

9.2         Europe Plant-based Vaccines Market Revenue Share, by Application (2021 and 2028)

9.3         Influenza

9.3.1        Overview

9.3.2        Influenza: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)

9.4         Zika Virus

9.4.1        Overview

9.4.2        Zika Virus: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)

9.5         Ebola Virus

9.5.1        Overview

9.5.2        Ebola Virus: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)

9.6         Poultry Disease

9.6.1        Overview

9.6.2        Poultry Disease: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)

9.7         Covid-19

9.7.1        Overview

9.7.2        COVID-19: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)

9.8         Others

9.8.1        Overview

9.8.2        Others: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)

10.        Europe Plant-based Vaccines Market – Country Analysis

10.1      Overview

10.1.1     Europe: Plant-based Vaccines Market, by Country, 2021 & 2028 (%)

10.1.1.1       Germany: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.1.1       Germany: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.1.2       Germany: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)

10.1.1.1.3       Germany: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)

10.1.1.1.4       Germany: Plant-based Vaccines Market, By Application– Revenue and Forecast to 2028 (USD Million)

10.1.1.2       France: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.2.1       France: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.2.2       France: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)

10.1.1.2.3       France: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)

10.1.1.2.4       France: Plant-based Vaccines Market, By Application– Revenue and Forecast to 2028 (USD Million)

10.1.1.3       UK: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.3.1       UK: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.3.2       UK: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)

10.1.1.3.3       UK: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)

10.1.1.3.4       UK: Plant-based Vaccines Market, By Application– Revenue and Forecast to 2028 (USD Million)

10.1.1.4       Italy: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.4.1       Italy: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.4.2       Italy: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)

10.1.1.4.3       Italy: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)

10.1.1.4.4       Italy: Plant-based Vaccines Market, By Application– Revenue and Forecast to 2028 (USD Million)

10.1.1.5       Spain: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.5.1       Spain: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.5.2       Spain: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)

10.1.1.5.3       Spain: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)

10.1.1.5.4       Spain: Plant-based Vaccines Market, By Application– Revenue and Forecast to 2028 (USD Million)

10.1.1.6       Rest of Europe: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.6.1       Rest of Europe: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.6.2       Rest of Europe: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)

10.1.1.6.3       Rest of Europe: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)

10.1.1.6.4       Rest of Europe: Plant-based Vaccines Market, By Application– Revenue and Forecast to 2028 (USD Million)

11.        Impact Of COVID-19 Pandemic On Europe Plant-based Vaccines Market

11.1      Europe: Impact Assessment of COVID-19 Pandemic

12.        Plant-based Vaccines Market –Industry Landscape

12.1      Overview

12.2      Growth Strategies in the Plant-based Vaccines Market, 2019-2021

12.3      Organic Developments

12.3.1     Overview

12.4      Inorganic Developments

12.4.1     Overview

13.        Company Profiles

13.1      British American Tobacco p.l.c.

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      ICON GENETICS GMBH

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      CREATIVE BIOLABS, INC.

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      LENIOBIO

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      LEAF EXPRESSION SYSTEMS LTD.

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      ZYUS LIFE SCIENCES INC.

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

LIST OF TABLES

Table 1.             Germany: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)

Table 2.             Germany: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)

Table 3.             Germany: Plant-based Vaccines Market, By Application – Revenue and Forecast to 2028 (USD Million).

Table 4.             France: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)

Table 5.             France: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)

Table 6.             France: Plant-based Vaccines Market, By Application – Revenue and Forecast to 2028 (USD Million).

Table 7.             UK: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)

Table 8.             UK: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)

Table 9.             UK: Plant-based Vaccines Market, By Application – Revenue and Forecast to 2028 (USD Million).

Table 10.          Italy: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)

Table 11.          Italy: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)

Table 12.          Italy: Plant-based Vaccines Market, By Application – Revenue and Forecast to 2028 (USD Million).

Table 13.          Spain: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)

Table 14.          Spain: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)

Table 15.          Spain: Plant-based Vaccines Market, By Application – Revenue and Forecast to 2028 (USD Million).

Table 16.          Rest of Europe: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)

Table 17.          Rest of Europe: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)

Table 18.          Rest of Europe: Plant-based Vaccines Market, By Application – Revenue and Forecast to 2028 (USD Million).

Table 19.          Recent organic developments in the Plant-based Vaccines Market

Table 20.          Glossary of Terms, Europe Plant-based vaccines devices market

LIST OF FIGURES

Figure 1.           Europe Plant-based Vaccines Market Segmentation

Figure 2.           Europe Plant-based Vaccines Market Segmentation, By Country

Figure 3.           Europe Plant-based Vaccines Market Overview

Figure 4.           Bacterial Vaccines Held the Largest Share of the Vaccine Type Segment in Europe Plant-based Vaccines Market

Figure 5.           Germany to Show Significant Growth during Forecast Period

Figure 6.           Europe PEST Analysis

Figure 7.           Europe Plant-Based Vaccines Market Impact Analysis of Driver and Restraints

Figure 8.           Europe Plant-based Vaccines Market– Revenue Forecast and Analysis – 2019- 2028

Figure 9.           Europe Plant-based Vaccines Market Revenue Share, by Vaccine Type (2021 and 2028)

Figure 10.        Europe Bacterial Vaccines: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)

Figure 11.        Europe Viral Vaccines: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)

Figure 12.        Europe Parasite Vaccines: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)

Figure 13.        Europe Plant-derived Virus-like particles (VLPs): Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)

Figure 14.        Europe Others: Plant-based Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Europe Plant-based Vaccines Market Revenue Share, by Source (2021 and 2028)

Figure 16.        Europe Tobacco Plant: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)

Figure 17.        Europe Maize: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)

Figure 18.        Europe Potato: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)

Figure 19.        Europe Others: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)

Figure 20.        Europe Plant-based Vaccines Market Revenue Share, by Application (2021 and 2028)

Figure 21.        Europe Influenza: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)

Figure 22.        Europe Zika Virus: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)

Figure 23.        Europe Ebola Virus: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)

Figure 24.        Europe Poultry Disease: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)

Figure 25.        Europe COVID-19: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)

Figure 26.        Europe Others: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)

Figure 27.        Europe: Plant-based Vaccines Market, by Key Country – Revenue (2021) (USD Million)

Figure 28.        Europe: Plant-based Vaccines Market, by Country, 2021 & 2028 (%)

Figure 29.        Germany: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)

Figure 30.        France: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)

Figure 31.        UK: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)

Figure 32.        Italy: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)

Figure 33.        Spain: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)

Figure 34.        Rest of Europe: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)

Figure 35.        Impact of COVID-19 Pandemic In European Country Markets

1. British American Tobacco p.l.c.
2. Creative Biolabs, Inc.     
3. Leaf Expression Systems Ltd.
4. LenioBio
5. Lumen Bioscience, Inc.
6. ZYUS Life Sciences Inc.

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe plant-based vaccines market
• Highlights key business priorities in order to assist companies to realign their business strategies
• The key findings and recommendations highlight crucial progressive industry trends in the Europe plant-based vaccines market, thereby allowing players across the value chain to develop effective long-term strategies
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
• Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the plant-based vaccines market, as well as those hindering it
• Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution